Invesco Biotechnology & Genome ETF Rating $69.56 +1.00 (+1.46%) (As of 11/22/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.74Holdings in PBE have an aggregate rating of Moderate Buy based on 402 analyst ratings issued in the past year covering 29 companies (97.3% of the portfolio).PBE Aggregate Price Target$69.56High Prediction$69.56Average Prediction$69.56Low Prediction$69.56Holdings in PBE have an aggregate price target of $69.56 and a range of $69.56 to $69.56 covering 29 companies (97.3% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.11%ILMNIllumina$140.14+2.3%4.6001 of 5 stars2.67$164.00 17.0%245.62%UTHRUnited Therapeutics$372.89+1.5%4.529 of 5 stars2.73$370.86 -0.5%15Insider TradeAnalyst RevisionNews CoveragePositive News5.05%AMGNAmgen$294.53+1.6%4.9281 of 5 stars2.46$333.57 13.3%26Analyst RevisionPositive News5.02%ALNYAlnylam Pharmaceuticals$244.89-0.8%4.5171 of 5 stars2.71$298.09 21.7%24Analyst ForecastAnalyst Revision4.45%BIIBBiogen$157.90-0.1%4.845 of 5 stars2.54$257.20 62.9%28Analyst Forecast4.12%NBIXNeurocrine Biosciences$125.65+0.5%4.9607 of 5 stars2.83$163.91 30.5%24Positive News3.80%BMRNBioMarin Pharmaceutical$64.26+1.3%4.9889 of 5 stars2.74$94.20 46.6%23Analyst RevisionNews Coverage3.79%EXELExelixis$35.61+2.2%4.8068 of 5 stars2.65$31.44 -11.7%20Insider TradeAnalyst RevisionNews Coverage3.75%MNKDMannKind$6.84-0.9%3.4708 of 5 stars3.14$8.67 26.7%7Analyst DowngradeInsider Trade3.59%REGNRegeneron Pharmaceuticals$738.00-0.9%4.8206 of 5 stars2.78$1,099.55 49.0%23News CoveragePositive News3.57%XNCRXencor$25.01+3.8%3.4354 of 5 stars3.00$35.75 42.9%83.28%INCYIncyte$71.72+1.9%4.0233 of 5 stars2.38$77.16 7.6%21Analyst Forecast3.15%PTGXProtagonist Therapeutics$46.46+11.5%2.3012 of 5 stars3.14$53.57 15.3%7Analyst ForecastAnalyst RevisionNews CoverageGap Up3.11%VCYTVeracyte$39.59+1.7%4.1695 of 5 stars2.78$41.25 4.2%93.04%TECHBio-Techne$71.28+0.3%4.8771 of 5 stars2.67$81.78 14.7%9News Coverage3.02%CPRXCatalyst Pharmaceuticals$21.48+1.7%4.7064 of 5 stars3.00$31.14 45.0%73.00%TGTXTG Therapeutics$35.07+1.5%3.6098 of 5 stars2.83$37.67 7.4%62.92%NTRANatera$167.26-1.2%2.8129 of 5 stars3.00$140.59 -15.9%17Insider TradeNews Coverage2.80%BPMCBlueprint Medicines$94.15-2.6%2.9051 of 5 stars2.71$122.11 29.7%21Analyst Revision2.72%RGENRepligen$142.58+0.6%4.6698 of 5 stars2.73$190.25 33.4%11Analyst UpgradeNews Coverage2.64%ACADACADIA Pharmaceuticals$16.37+1.2%3.6892 of 5 stars2.65$25.56 56.2%17Insider TradeAnalyst RevisionNews Coverage2.63%HALOHalozyme Therapeutics$49.00+7.2%4.934 of 5 stars2.60$61.11 24.7%10Analyst ForecastNews CoverageGap UpHigh Trading Volume2.55%OPKOPKO Health$1.58+1.3%4.4003 of 5 stars3.00$2.75 74.1%3Insider Trade2.54%BCRXBioCryst Pharmaceuticals$7.60+1.5%4.1871 of 5 stars2.80$15.60 105.3%52.46%COLLCollegium Pharmaceutical$29.96-1.5%4.0657 of 5 stars2.60$42.60 42.2%5Positive News2.35%VCELVericel$59.11+4.2%1.1004 of 5 stars3.00$58.14 -1.6%7Analyst ForecastPositive News2.33%NVAXNovavax$8.47+5.3%3.6805 of 5 stars2.33$17.83 110.5%6Analyst Revision2.05%CDNACareDx$23.13+2.4%3.8323 of 5 stars2.43$29.60 28.0%71.84%MYGNMyriad Genetics$15.49+2.4%4.2879 of 5 stars2.42$27.36 76.7%12Analyst Downgrade This page (NYSEARCA:PBE) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
